Similar Articles

• Intersection of Metastatic Cancer, Chemotherapy, and Reported Physical Abuse/Assault-Related Trauma: A Nationwide Analysis

  Abdul R. Shour, Heather X Rhodes, David Puthoff, Rohit Sharma and Adedayo A. Onitilo

  • Clinical Medicine & Research December 2025, 23 (4) 137-150;
  • DOI: https://doi.org/10.3121/cmr.2025.1989
• PS2-05: The Readiness of U.S. Health Plans to Manage Cardiometabolic Risk

  Thomas E Kottke, Courtney O Jordan, Patrick J O’Connor, Nicolaas P Pronk and Rita Carreón

  • Clinical Medicine & Research March 2010, 8 (1) 37;
  • DOI: https://doi.org/10.3121/cmr.8.1.37-b
• C-B2-01: Cardiotoxic Chemotherapy is Associated with Increased Heart Failure Risk Among Women with Breast Cancer in the Cancer Research Network

  Erin Aiello Bowles, Robert Wellman, Thomas Delate, Larry Allen, Heather Spencer Feigelson, Marianne Ulcickas Yood, Robert Davis, Larissa Nekhlyudov, Catherine McCarty, Laurel Habel, David Magid, Adedayo Onitilo, Andrew Freedman and Edward Wagner

  • Clinical Medicine & Research November 2011, 9 (3-4) 148;
  • DOI: https://doi.org/10.3121/cmr.2011.1020.c-b2-01
• Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) as a Neoadjuvant Chemotherapy for Non-metastatic Esophageal Cancer (nMEC)

  Adedayo A. Onitilo, Trista J Stankowski-Drengler, Oyewale Shiyanbola, Jessica Engel, Sabo Tanimu, Seth O Fagbemi and Ya-Huei Li

  • Clinical Medicine & Research March 2021, cmr.2021.1573;
  • DOI: https://doi.org/10.3121/cmr.2021.1573
• Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) as a Neoadjuvant Chemotherapy for Non-metastatic Esophageal Cancer (nMEC)

  Adedayo A. Onitilo, Trista J. Stankowski-Drengler, Oyewale Shiyanbola, Jessica Engel, Sabo Tanimu, Seth O. Fagbemi and Ya-Huei Li

  • Clinical Medicine & Research June 2021, 19 (2) 64-71;
  • DOI: https://doi.org/10.3121/cmr.2021.1573
• Body Mass Index Measurement and Obesity Prevalence in Ten U.S. Health Plans

  David E. Arterburn, Gwen L. Alexander, Josephine Calvi, Laura A. Coleman, Matthew W. Gillman, Rachel Novotny, Virginia P. Quinn, Margaret Rukstalis, Victor J. Stevens, Elsie M. Taveras and Nancy E. Sherwood

  • Clinical Medicine & Research December 2010, 8 (3-4) 126-130;
  • DOI: https://doi.org/10.3121/cmr.2010.880
• Body Mass Index Measurement and Obesity Prevalence in Ten U.S. Health Plans

  David E. Arterburn, Gwen L. Alexander, Josephine Calvi, Laura A. Coleman, Matthew W. Gillman, Rachel Novotny, Virginia P. Quinn, Margaret Rukstalis, Victor J. Stevens, Elsie M. Taveras and Nancy E. Sherwood

  • Clinical Medicine & Research August 2010, cmr.2010.880;
  • DOI: https://doi.org/10.3121/cmr.2010.880
• Body Mass Index Measurement and Obesity Prevalence in Ten U.S. Health Plans

  David E. Arterburn, Gwen L. Alexander, Josephine Calvi, Laura A. Coleman, Matthew W. Gillman, Rachel Novotny, Virginia P. Quinn, Margaret Rukstalis, Victor J. Stevens, Elsie M. Taveras and Nancy E. Sherwood

  • Clinical Medicine & Research August 2010, cmr.2010.880;
  • DOI: https://doi.org/10.3121/cmr.2010.880
• CB8-01: Prevalence of Elevated Blood Pressure and BMI in U.S. Children and Adolescents

  Patrick O’Connor, Emily Parker, Jay Desai, David Magid, Kenneth Adams, Karen Margolis, Matthew Daley, Alan Sinaiko, Elyse Kharbanda and Joan Lo

  • Clinical Medicine & Research August 2012, 10 (3) 188-189;
  • DOI: https://doi.org/10.3121/cmr.2012.1100.cb8-01
• PS1-30: Cost-Effectiveness Analysis of Screening for Kras and Braf Genetic Mutations in Metastatic Colorectal Cancer

  Ajay Behl

  • Clinical Medicine & Research November 2011, 9 (3-4) 174;
  • DOI: https://doi.org/10.3121/cmr.2011.1020.ps1-30

Previous

Next

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• …
• 194